Claes H. Dohlman,
MD, PhD
Massachusetts Eye and Ear
Senior Scientist
Harvard Medical School
Professor of Ophthalmology, Emeritus
claes_dohlman@meei.harvard.edu
For investigator inquiries only
About My Research
Center/Research Area Affiliations
Biography
Long considered a pioneer of modern corneal science, Dr. Dohlman established the Cornea Service and the Cornea Fellowship program at Mass. Eye and Ear in 1960. He is the developer of the Boston Keratoprosthesis (Boston KPro), an artificial cornea that offers hope to many patients for whom a standard corneal transplant is not a viable option. More than 9,000 patients in the United States and in 52 countries worldwide have received a Boston KPro. Dr. Dohlman continues a robust Boston KPro research program with a number of coworkers that addresses simplicity, cost and long-term safety for the device, especially for the developing world.
Education
1950: "Medicine Licentiat" (MD), University of Lund, Sweden
1957: "Medicine Doktor" (PhD) and "Docent," University of Lund, Sweden
>Postgraduate Training
1950-1951: Resident in Ophthalmology, University of Lund, Sweden
1952-1953: Research Fellow in Ophthalmology, Johns Hopkins Hospital, Baltimore, MD
1953: Research Fellow, Stanford University Hospital, San Francisco
1953-1954: Research Fellow, Retina Foundation, Boston, MA
1954-1958: Staff, Department of Ophthalmology, University of Lund, Sweden
1956: Research Fellow, Department of Biochemistry, Karolinksa Institute, Stockholm, Sweden
1958: Visiting Ophthalmologist, Eduard Herriot Hospital, Lyon, France
1958-1963: Fellow in Ophthalmology, Mass. Eye and Ear
1958-1962: Research Associate, Retina Foundation, Boston, MA
Academic Appointments
1961-1967: Instructor in Ophthalmology, Harvard Medical School
1967-1968: Clinical Associate in Ophthalmology, Harvard Medical School
1968-1969: Assistant Professor of Ophthalmology, Harvard Medical School
1969-1973: Associate Professor of Ophthalmology, Harvard Medical School
1974-present: Professor of Ophthalmology, Harvard Medical School
1974-1989: Chairman, Department of Ophthalmology, Harvard Medical School
1974-1989: Director, Howe Laboratory of Ophthalmology, Harvard Medical School
Professional Memberships
1967-present: Member, Association for Research in Vision and Ophthalmology
1970-1983: Member, American Society of Contemporary Ophthalmology
1970-present: Member, American Academy of Ophthalmology
1970-present: Member, International Eye Foundation Society of Eye Physicians
1970-present: Member, New England Ophthalmological Society
1970-present: Member, Pan American Association of Ophthalmology
1974-1989: Member, Association of University Professors of Ophthalmology
1975-present: Member, American Medical Association
1975-present: Member, Massachusetts Medical Society
1975-present: Member, Massachusetts Ophthalmological Society
1975-present: Member, Castroviejo Society
1981-present: Member, International Society for Eye Research
Honors (select)
1966: New England Ophthalmological Society Award Order of Vasa, Sweden
1971: Friedenwald Award for Research in Ophthalmology
1972: Bjerrum Award, Denmark
1973: Honorary Member, Swedish Ophthalmological Society
1981: Castroviejo Medal
1984: Residents Teacher of the Year Award, Mass. Eye and Ear
1984: Senior Honor Award, American Academy of Ophthalmology
1986: Man of Vision Award, Mass. Society to Prevent Blindness
1994: Residents Teacher of the Year Award, Mass. Eye and Ear
1995: Man of Vision Award, Boston Aid to the Blind
1998: Residents Teacher of the Year Award, Mass. Eye and Ear
1998: Distinguished Service Award, given as the sole recipient at the 175th Anniversary of Mass. Eye and Ear
Publications powered by Harvard Catalyst Profiles
- The prophylactic value of TNF-a inhibitors against retinal cell apoptosis and optic nerve axon loss after corneal surgery or trauma. Acta Ophthalmol. 2024 May; 102(3):e381-e394.
- Opposing Roles of Blood-Borne Monocytes and Tissue-Resident Macrophages in Limbal Stem Cell Damage after Ocular Injury. Cells. 2023 08 18; 12(16).
- Sustained Inhibition of VEGF and TNF-a Achieves Multi-Ocular Protection and Prevents Formation of Blood Vessels after Severe Ocular Trauma. Pharmaceutics. 2023 Jul 31; 15(8).
- The Boston Keratoprosthesis-The First 50 Years: Some Reminiscences. Annu Rev Vis Sci. 2022 09 15; 8:1-32.
- Crosslinker-free collagen gelation for corneal regeneration. Sci Rep. 2022 06 01; 12(1):9108.
- Graphene-Lined Porous Gelatin Glycidyl Methacrylate Hydrogels: Implications for Tissue Engineering. ACS Appl Nano Mater. 2021 Nov 26; 4(11):12650-12662.
- Critical media attributes in E-beam sterilization of corneal tissue. Acta Biomater. 2022 01 15; 138:218-227.
- Photo-cross-linked Gelatin Glycidyl Methacrylate/N-Vinylpyrrolidone Copolymeric Hydrogel with Tunable Mechanical Properties for Ocular Tissue Engineering Applications. ACS Appl Bio Mater. 2021 10 18; 4(10):7682-7691.
- Optimization of Collagen Chemical Crosslinking to Restore Biocompatibility of Tissue-Engineered Scaffolds. Pharmaceutics. 2021 Jun 03; 13(6).
- Tuning gelatin-based hydrogel towards bioadhesive ocular tissue engineering applications. Bioact Mater. 2021 Nov; 6(11):3947-3961.
- Combined blockade of complement C5 and TLR co-receptor CD14 synergistically inhibits pig-to-human corneal xenograft induced innate inflammatory responses. Acta Biomater. 2021 06; 127:169-179.
- Toward electron-beam sterilization of a pre-assembled Boston keratoprosthesis. Ocul Surf. 2021 04; 20:176-184.
- Electron Beam Sterilization of Poly(Methyl Methacrylate)-Physicochemical and Biological Aspects. Macromol Biosci. 2021 04; 21(4):e2000379.
- Sputter Deposition of Titanium on Poly(Methyl Methacrylate) Enhances Corneal Biocompatibility. Transl Vis Sci Technol. 2020 12; 9(13):41.
- The Search for Antifungal Prophylaxis After Artificial Corneal Surgery-An In Vitro Study. Cornea. 2020 Dec; 39(12):1547-1555.
- Intrinsic Optical Properties of Boston Keratoprosthesis. Transl Vis Sci Technol. 2020 11; 9(12):10.
- Glaucoma after Ocular Surgery or Trauma: The Role of Infiltrating Monocytes and Their Response to Cytokine Inhibitors. Am J Pathol. 2020 10; 190(10):2056-2066.
- Microporous Drug Delivery System for Sustained Anti-VEGF Delivery to the Eye. Transl Vis Sci Technol. 2020 07; 9(8):5.
- Angle Anatomy and Glaucoma in Patients With Boston Keratoprosthesis. Cornea. 2020 Jun; 39(6):713-719.
- Implantable self-aligning fiber-optic optomechanical devices for in vivo intraocular pressure-sensing in artificial cornea. J Biophotonics. 2020 07; 13(7):e202000031.
- Glaucoma After Corneal Trauma or Surgery-A Rapid, Inflammatory, IOP-Independent Pathway. Cornea. 2019 Dec; 38(12):1589-1594.
- Three-Dimensional Optical Coherence Tomography Imaging For Glaucoma Associated With Boston Keratoprosthesis Type I and II. J Glaucoma. 2019 08; 28(8):718-726.
- Effects of gamma radiation sterilization on the structural and biological properties of decellularized corneal xenografts. Acta Biomater. 2019 09 15; 96:330-344.
- Glaucoma Management in Patients With Aniridia and Boston Type 1 Keratoprosthesis. Am J Ophthalmol. 2019 11; 207:258-267.
- Finding an Optimal Corneal Xenograft Using Comparative Analysis of Corneal Matrix Proteins Across Species. Sci Rep. 2019 02 12; 9(1):1876.
- Blood Levels of Tumor Necrosis Factor Alpha and Its Type 2 Receptor Are Elevated in Patients with Boston Type I Keratoprosthesis. Curr Eye Res. 2019 06; 44(6):599-606.
- Microglia Regulate Neuroglia Remodeling in Various Ocular and Retinal Injuries. J Immunol. 2019 01 15; 202(2):539-549.
- Permanent neuroglial remodeling of the retina following infiltration of CSF1R inhibition-resistant peripheral monocytes. Proc Natl Acad Sci U S A. 2018 11 27; 115(48):E11359-E11368.
- The Role of Microglia and Peripheral Monocytes in Retinal Damage after Corneal Chemical Injury. Am J Pathol. 2018 07; 188(7):1580-1596.
- Improving the practicality and safety of artificial corneas: Pre-assembly and gamma-rays sterilization of the Boston Keratoprosthesis. Ocul Surf. 2018 07; 16(3):322-330.
- Chemical Burns of the Eye: The Role of Retinal Injury and New Therapeutic Possibilities. Cornea. 2018 Feb; 37(2):248-251.
- Colocalization of Galectin-3 With CD147 Is Associated With Increased Gelatinolytic Activity in Ulcerating Human Corneas. Invest Ophthalmol Vis Sci. 2018 01 01; 59(1):223-230.
- Surface Modifications of the PMMA Optic of a Keratoprosthesis to Improve Biointegration. Cornea. 2017 Nov; 36 Suppl 1:S15-S25.
- The Role of the Back Plate in Angle Anatomy with the Boston Type I Keratoprosthesis. Cornea. 2017 Sep; 36(9):1096-1101.
- Measuring Forward Light Scatter by the Boston Keratoprosthesis in Various Configurations. Cornea. 2017 Jun; 36(6):732-735.
- Mechanisms of Retinal Damage after Ocular Alkali Burns. Am J Pathol. 2017 Jun; 187(6):1327-1342.
- Endoscopic Cyclophotocoagulation for the Treatment of Glaucoma in Boston Keratoprosthesis Type II Patient. J Glaucoma. 2017 Apr; 26(4):e146-e149.
- Elevated Neutrophil Elastase in Tears of Ocular Graft-Versus-Host Disease Patients. Am J Ophthalmol. 2017 Apr; 176:46-52.
- Sustained Subconjunctival Delivery of Infliximab Protects the Cornea and Retina Following Alkali Burn to the Eye. Invest Ophthalmol Vis Sci. 2017 01 01; 58(1):96-105.
- Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation. Ophthalmology. 2017 01; 124(1):27-35.
- Boston keratoprosthesis type I in the elderly. Br J Ophthalmol. 2017 04; 101(4):514-518.
- Tear Matrix Metalloproteinases and Myeloperoxidase Levels in Patients With Boston Keratoprosthesis Type I. Cornea. 2016 Jul; 35(7):1008-14.
- Titanium Coating of the Boston Keratoprosthesis. Transl Vis Sci Technol. 2016 Apr; 5(2):17.
- Effect of Penetrating Keratoplasty and Keratoprosthesis Implantation on the Posterior Segment of the Eye. Invest Ophthalmol Vis Sci. 2016 Apr; 57(4):1643-8.
- Infliximab after Boston Keratoprosthesis in Stevens-Johnson Syndrome: An Update. Ocul Immunol Inflamm. 2017 Jun; 25(3):413-417.
- A Drug Delivery System for Administration of Anti-TNF-a Antibody. Transl Vis Sci Technol. 2016 Mar; 5(2):11.
- Establishment of a novel in vitro model of stratified epithelial wound healing with barrier function. Sci Rep. 2016 Jan 13; 6:19395.
- Fungal Infections in Boston Keratoprosthesis Patients: Lessons Learned and Novel Developments on the Horizon. Semin Ophthalmol. 2016; 31(1-2):71-84.
- Retinal detachments after Boston Keratoprosthesis: incidence, predisposing factors, and visual outcomes. Digit J Ophthalmol. 2015; 21(4):1-15.
- Fungal Infections After Boston Type 1 Keratoprosthesis Implantation: Literature Review and In Vitro Antifungal Activity of Hypochlorous Acid. Cornea. 2015 Dec; 34(12):1599-605.
- Incidence of Stevens-Johnson Syndrome and Chemical Burns to the Eye. Cornea. 2015 Dec; 34(12):1527-33.
- Periprosthetic Tissue Loss in Patients With Idiopathic Vitreous Inflammation After the Boston Keratoprosthesis. Cornea. 2015 Nov; 34(11):1378-82.
- Protective effect of soft contact lenses after Boston keratoprosthesis. Br J Ophthalmol. 2016 Apr; 100(4):549-52.
- Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases. Cornea. 2015 Mar; 34(3):264-70.
- Emergency eye rinse for chemical injuries: new considerations. JAMA Ophthalmol. 2015 Mar; 133(3):245.
- Idiopathic vitritis in the setting of Boston keratoprosthesis. Cornea. 2015 Feb; 34(2):165-70.
- Corneal inflammation after miniature keratoprosthesis implantation. Invest Ophthalmol Vis Sci. 2014 Dec 16; 56(1):185-9.
- The Boston keratoprosthesis provides a wide depth of focus. Ophthalmic Physiol Opt. 2015 Jan; 35(1):39-44.
- UV cross-linking of donor corneas confers resistance to keratolysis. Cornea. 2014 Sep; 33(9):955-9.
- A review of corneal melting after Boston Keratoprosthesis. Semin Ophthalmol. 2014 Sep-Nov; 29(5-6):349-57.
- Stability and in vitro toxicity of an infliximab eye drop formulation. Int J Pharm Compd. 2014 Sep-Oct; 18(5):418-26.
- A novel murine model for keratoprosthesis. Invest Ophthalmol Vis Sci. 2014 May 15; 55(6):3681-5.
- Alkali burn to the eye: protection using TNF-a inhibition. Cornea. 2014 Apr; 33(4):382-9.
- Glaucoma progression and role of glaucoma surgery in patients with Boston keratoprosthesis. Cornea. 2014 Apr; 33(4):349-54.
- [The Boston keratoprosthesis]. Zhonghua Yan Ke Za Zhi. 2014 Apr; 50(4):307-12.
- Very low risk of light-induced retinal damage during Boston keratoprosthesis surgery: a rabbit study. Cornea. 2014 Feb; 33(2):184-90.
- Infectious endophthalmitis in Boston keratoprosthesis: incidence and prevention. Acta Ophthalmol. 2014 Nov; 92(7):e546-55.
- Reliable intraocular pressure measurement using automated radio-wave telemetry. Clin Ophthalmol. 2014; 8:177-85.
- Wound anatomy after type 1 Boston KPro using oversized back plates. Cornea. 2013 Dec; 32(12):1531-6.
- Low-cost and readily available tissue carriers for the Boston keratoprosthesis: a review of possibilities. J Ophthalmol. 2013; 2013:686587.
- Neutrophil collagenase, gelatinase, and myeloperoxidase in tears of patients with stevens-johnson syndrome and ocular cicatricial pemphigoid. Ophthalmology. 2014 Jan; 121(1):79-87.
- The Boston keratoprosthesis type I in mucous membrane pemphigoid. Cornea. 2013 Jul; 32(7):956-61.
- A novel implantable glaucoma valve using ferrofluid. PLoS One. 2013; 8(6):e67404.
- In vitro and in vivo assessment of titanium surface modification for coloring the backplate of the Boston keratoprosthesis. Invest Ophthalmol Vis Sci. 2013 Jun 04; 54(6):3863-73.
- Wide-angle fundus imaging through the Boston keratoprosthesis. Retina. 2013 Jun; 33(6):1188-92.
- Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis. Am J Ophthalmol. 2012 Jul; 154(1):207-8; author reply 208-9.
- Oral acetazolamide after Boston keratoprosthesis in Stevens-Johnson syndrome. BMC Res Notes. 2012 Apr 30; 5:205.
- Intraocular pressure measurement by radio wave telemetry. Invest Ophthalmol Vis Sci. 2011 Dec 20; 52(13):9573-80.
- Glaucoma in eyes with severe chemical burn, before and after keratoprosthesis. Cornea. 2011 Dec; 30(12):1322-7.
- The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience. Cornea. 2011 Dec; 30(12):1298-303.
- Prevention of visually debilitating deposits on soft contact lenses in keratoprosthesis patients. Cornea. 2011 Dec; 30(12):1419-22.
- Keratoprosthesis in congenital hereditary endothelial dystrophy after multiple failed grafts. Digit J Ophthalmol. 2011; 17(3):43-5.
- Hydroxyapatite for keratoprosthesis biointegration. Invest Ophthalmol Vis Sci. 2011 Sep 22; 52(10):7392-9.
- Biocompatibility and biofilm inhibition of N,N-hexyl,methyl-polyethylenimine bonded to Boston Keratoprosthesis materials. Biomaterials. 2011 Dec; 32(34):8783-96.
- Chemical burns to the eye: paradigm shifts in treatment. Cornea. 2011 Jun; 30(6):613-4.
- Titanium back plate for a PMMA keratoprosthesis: clinical outcomes. Graefes Arch Clin Exp Ophthalmol. 2011 Oct; 249(10):1515-8.
- Characterization of retrokeratoprosthetic membranes in the Boston type 1 keratoprosthesis. Arch Ophthalmol. 2011 Mar; 129(3):310-6.
- Keratoprosthesis in the fight against corneal blindness in developing countries. Arq Bras Oftalmol. 2011 Jan-Feb; 74(1):5-6.
- Cost effectiveness of the type II Boston keratoprosthesis. Eye (Lond). 2011 Mar; 25(3):342-9.
- Keratoprosthesis in autoimmune disease. Ocul Immunol Inflamm. 2010 Aug; 18(4):275-80.
- Global corneal blindness and the Boston keratoprosthesis type I. Am J Ophthalmol. 2010 Apr; 149(4):537-9.
- Shunts to divert aqueous humor to distant epithelialized cavities after keratoprosthesis surgery. J Glaucoma. 2010 Feb; 19(2):111-5.
- Cost-effectiveness of the Boston keratoprosthesis. Am J Ophthalmol. 2010 Feb; 149(2):221-228.e2.
- Optical functional properties of the Boston Keratoprosthesis. Invest Ophthalmol Vis Sci. 2010 Feb; 51(2):857-63.
- Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea. 2009 Sep; 28(8):896-901.
- The Boston Keratoprosthesis: comparing corneal epithelial cell compatibility with titanium and PMMA. Cornea. 2009 Aug; 28(7):808-11.
- Contact lenses for drug delivery. Semin Ophthalmol. 2009 May-Jun; 24(3):156-60.
- Glaucoma and keratoprosthesis surgery: role of adjunctive cyclophotocoagulation. J Glaucoma. 2009 Apr-May; 18(4):321-4.
- Boston Keratoprosthesis in Stevens-Johnson syndrome: a case of using infliximab to prevent tissue necrosis. Digit J Ophthalmol. 2009; 15(1):5-8.
- A drug-eluting contact lens. Invest Ophthalmol Vis Sci. 2009 Jul; 50(7):3346-52.
- Biologic keratoprosthesis materials. Int Ophthalmol Clin. 2009; 49(1):1-9.
- Boston keratoprosthesis in epithelial downgrowth. Digit J Ophthalmol. 2009; 15(1):1-4.
- Testing the long term stability of vancomycin ophthalmic solution. Int J Pharm Compd. 2008 Sep-Oct; 12(5):456-9.
- The Boston Keratoprosthesis in severe ocular trauma. Can J Ophthalmol. 2008 Apr; 43(2):165-9.
- Boston keratoprosthesis treatment of herpes zoster neurotrophic keratopathy. Ophthalmology. 2008 Feb; 115(2 Suppl):S21-3.
- The Boston keratoprosthesis in Stevens-Johnson syndrome. Am J Ophthalmol. 2008 Mar; 145(3):438-44.
- The role of soft contact lenses as an adjunct to the Boston keratoprosthesis. Int Ophthalmol Clin. 2008; 48(2):43-51.
- Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study. Am J Ophthalmol. 2007 Aug; 144(2):227-231.
- The Boston keratoprosthesis in herpetic keratitis. Arch Ophthalmol. 2007 Jun; 125(6):745-9.
- Importance of nutrition to corneal grafts when used as a carrier of the Boston Keratoprosthesis. Cornea. 2007 Jun; 26(5):564-8.
- Fungal colonization and infection in Boston keratoprosthesis. Cornea. 2007 Jan; 26(1):9-15.
- Advances in Boston keratoprosthesis: enhancing retention and prevention of infection and inflammation. Int Ophthalmol Clin. 2007; 47(2):61-71.
- Sudden reversible vitritis after keratoprosthesis: an immune phenomenon? Cornea. 2005 Nov; 24(8):915-9.
- Repeat penetrating keratoplasty versus the Boston keratoprosthesis in graft failure. Int Ophthalmol Clin. 2005; 45(4):49-59.
- Oculoplastic technique of connecting a glaucoma valve shunt to extraorbital locations in cases of severe glaucoma. Ophthalmic Plast Reconstr Surg. 2004 Sep; 20(5):362-7.
- Blindness in an American boy caused by unrecognized vitamin A deficiency. Arch Ophthalmol. 2004 Aug; 122(8):1228-9.
- Corneal oedema in ocular hypotony. Exp Eye Res. 2004 Mar; 78(3):549-52.
- A recollection from Boston. Exp Eye Res. 2004 Mar; 78(3):xxi-xxii.
- Histopathology of explanted collar button keratoprostheses: a clinicopathologic correlation. Cornea. 2003 Jul; 22(5):424-8.
- Neutrophil and eosinophil participation in atopic and vernal keratoconjunctivitis. Curr Eye Res. 2003 Jun; 26(6):319-25.
- Personal profile. Ocul Surf. 2003 Apr; 1(2):87-8.
- David M. Maurice, PhD (1922-2002). Arch Ophthalmol. 2003 Feb; 121(2):298.
- Management of vitreoretinal complications in eyes with permanent keratoprosthesis. Arch Ophthalmol. 2002 May; 120(5):559-66.
- Protection of the ocular surface after keratoprosthesis surgery: the role of soft contact lenses. CLAO J. 2002 Apr; 28(2):72-4.
- Mechanisms of corneal ulceration. Ophthalmol Clin North Am. 2002 Mar; 15(1):27-33.
- Corneal blindness from end-stage Sjögren's syndrome and graft-versus-host disease. Adv Exp Med Biol. 2002; 506(Pt B):1335-8.
- Keratoprosthesis: an update. Curr Opin Ophthalmol. 2001 Aug; 12(4):282-7.
- Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers. Arch Ophthalmol. 2001 May; 119(5):659-63.
- Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol. 2001 Apr; 119(4):484-9.
- Candidal endophthalmitis after keratoplasty. Cornea. 2001 Mar; 20(2):226-9.
- Keratoprosthesis: preoperative prognostic categories. Cornea. 2001 Jan; 20(1):19-23.
- Survey of patients with granular, lattice, avellino, and Reis-Bücklers corneal dystrophies for mutations in the BIGH3 and gelsolin genes. Arch Ophthalmol. 2001 Jan; 119(1):16-22.
- Causes of enlarged corneal nerves. Int Ophthalmol Clin. 2001; 41(1):13-23.
- Neurotrophic keratitis. Int Ophthalmol Clin. 2001; 41(1):1-11.
- Can an eye in phthisis be rehabilitated? A case of improved vision with 1-year follow-up. Arch Ophthalmol. 1999 Jan; 117(1):123-4.
- Innovations in keratoprosthesis: proved and unproved. Int Ophthalmol Clin. 1999; 39(1):27-36.
- Glaucoma associated with keratoprosthesis. Ophthalmology. 1998 Apr; 105(4):751-7.
- Keratoprosthesis in pemphigoid and Stevens-Johnson syndrome. Adv Exp Med Biol. 1998; 438:1021-5.
- Fabrication of a keratoprosthesis. Cornea. 1996 Mar; 15(2):179-84.
- Adjunctive therapy and surgical considerations in the management of bacterial ulcerative keratitis. Int Ophthalmol Clin. 1996; 36(3):37-48.
- Vernal keratoconjunctivitis. Int Ophthalmol Clin. 1996; 36(1):15-20.
- Some factors influencing outcome after keratoprosthesis surgery. Cornea. 1994 May; 13(3):214-8.
- The role of steroids in the management of Acanthamoeba keratitis, fungal keratitis, and epidemic keratoconjunctivitis. Int Ophthalmol Clin. 1994; 34(3):19-31.
- Keratoprosthesis in end-stage dry eye. Adv Exp Med Biol. 1994; 350:561-4.
- Is keratoconus genetic? Int Ophthalmol Clin. 1993; 33(2):249-60.
- Epithelial downgrowth--fistula repair and keratoplasty. Refract Corneal Surg. 1991 Jan-Feb; 7(1):23-7.
- Johan Lorenz Odhelius and cataract extraction in Sweden. Acta Ophthalmol Suppl (1985). 1989; 192:11-6.
- Paraproteinemic crystalline keratopathy. Ophthalmology. 1988 Feb; 95(2):202-12.
- Dry eyes--aspects of pathophysiology. Fortschr Ophthalmol. 1987; 84(5):443-5.
- Treatment of superior limbic keratoconjunctivitis by thermocauterization of the superior bulbar conjunctiva. Ophthalmology. 1986 Feb; 93(2):162-6.
- Morphologic characteristics of posterior polymorphous dystrophy. A study of nine corneas and review of the literature. Surv Ophthalmol. 1984 Sep-Oct; 29(2):139-47.
- Idoxuridine-induced conjunctival cicatrization. Arch Ophthalmol. 1983 May; 101(5):747-50.
- Iridoplasty for prevention of post-keratoplasty angle closure and glaucoma. Ophthalmic Surg. 1982 Dec; 13(12):994-6.
- Medroxyprogesterone on corneal ulceration. Its effects after alkali burns on rabbits. Arch Ophthalmol. 1981 Apr; 99(4):673-6.
- Corneal donor material selection. Ophthalmology. 1981 Feb; 88(2):139-45.
- Posterior subcapsular cataracts induced by topical corticosteroids following keratoplasty for keratoconus. Ann Ophthalmol. 1981 Jan; 13(1):29-32.
- Recurrent keratoconus after keratoplasty. Am J Ophthalmol. 1980 Nov; 90(5):672-6.
- Corneal wrinkling induced by ultra-thin soft contact lenses. Ann Ophthalmol. 1980 Apr; 12(4):371-5.
- Effect of bilateral and unilateral grafts on the incidence of rejections in keratoconus. Am J Ophthalmol. 1979 Jun; 87(6):823-6.
- Oversize corneal donor grafts in penetrating keratoplasty. Ophthalmology. 1979 Mar; 86(3):490-4.
- Punctal occlusion in keratoconjunctivitis sicca. Ophthalmology. 1978 Dec; 85(12):1277-81.
- Effect of topical corticosteroids on ulceration in alkali-burned corneas. Arch Ophthalmol. 1978 Nov; 96(11):2117-20.
- Corneal donor material selection. Am J Ophthalmol. 1978 Nov; 86(5):605-10.
- Penetration routes of topically applied eye medications. Am J Ophthalmol. 1978 Mar; 85(3):383-6.
- Surface activity determination of aqueous tear components in dry eye patients and normals. Exp Eye Res. 1977 May; 24(5):479-91.
- Intraocular lens implantation in combination with keratoplasty. Ann Ophthalmol. 1977 Apr; 9(4):513-8.
- The pathogenesis and treatment of persistent epithelial defects. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1976 Sep-Oct; 81(5):754-69.
- The glycoprotein (mucus)content of tears from normals and dry eye patients. Exp Eye Res. 1976 Apr; 22(4):359-65.
- Surface ultrastructure in alkali-burned rabbit corneas. Am J Ophthalmol. 1976 Mar; 81(3):324-31.
- Corneal thickness in glaucoma. Ann Ophthalmol. 1976 Feb; 8(2):177-82.
- Clinical experience with a mobile ocular perfusion pump. Arch Ophthalmol. 1975 Oct; 93(10):1039-43.
- Corneal epithelial preservation. Arch Ophthalmol. 1975 May; 93(5):357-61.
- Is the lacrimal gland dispensable? Keratoconjunctivitis sicca after lacrimal gland removal. Arch Ophthalmol. 1975 Apr; 93(4):281-3.
- Comparison of suturing techniques in keratoplasty for keratoconus. Ann Ophthalmol. 1975 Mar; 7(3):433-6.
- Collagenase inhibitors. Arch Ophtalmol Rev Gen Ophtalmol. 1975 Jan; 35(1):95-112.
- Antiviral medication and corneal wound healing. Arch Ophthalmol. 1974 Dec; 92(6):509-13.
- Complications in therapeutic soft lens wear. Trans Am Acad Ophthalmol Otolaryngol. 1974 May-Jun; 78(3):OP399-405.
- Prosthokeratoplasty. Am J Ophthalmol. 1974 May; 77(5):694-70.
- Gaucoma following keratoplasty. Trans Am Acad Ophthalmol Otolaryngol. 1974 Mar-Apr; 78(2):OP352-64.
- Tear volume in normal eyes and keratoconjunctivitis sicca. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1974; 192(2):141-50.
- Complications in use of soft contact lenses in corneal disease. Arch Ophthalmol. 1973 Nov; 90(5):367-71.
- Diffuse subepithelial infiltrates of epidemic keratoconjunctivitis. Arch Ophthalmol. 1973 Nov; 90(5):407.
- Intraocular penetration of Ara A and idu-therapeutic implications in clinical herpetic uveitis. Trans Am Acad Ophthalmol Otolaryngol. 1973 Jul-Aug; 77(4):OP455-66.
- Return of goblet cells after vitamin A therapy in xerosis of the conjunctiva. Am J Ophthalmol. 1973 Apr; 75(4):720-5.
- A new ocular insert device for continuous constant-rate delivery of medication to the eye. Ann Ophthalmol. 1972 Oct; 4(10):823-32.
- Cornea in hypovitaminosis A and protein deficiency. Isr J Med Sci. 1972 Aug-Sep; 8(8):1179-83.
- A double blind clinical study of adenine arabinoside therapy of viral keratoconjunctivitis. Am J Ophthalmol. 1972 Jul; 74(1):81-8.
- Recurrence of herpetic keratitis in corneal grafts. Am J Ophthalmol. 1972 Feb; 73(2):192-6.
- Corneal cysts. A report of eight cases. Arch Ophthalmol. 1971 Dec; 86(6):648-52.
- Corneal glucose flux. II. Its response to anterior chamber blockade and endothelial damage. Arch Ophthalmol. 1971 Dec; 86(6):685-91.
- Prevention of corneal ulcers. Trans Am Acad Ophthalmol Otolaryngol. 1971 Nov-Dec; 75(6):1208-11.
- Dry eye secondary to mucus deficiency. Trans Am Acad Ophthalmol Otolaryngol. 1971 Nov-Dec; 75(6):1223-7.
- Collagenase activity of intact corneal epithelium in peripheral alkali burns. Arch Ophthalmol. 1971 Sep; 86(3):308-13.
- Anterior segment necrosis in rabbits. Metabolic and histologic changes. Arch Ophthalmol. 1971 Sep; 86(3):301-7.
- The anterior segments of rabbits after alkali burns. Metabolic and histologic alterations. Arch Ophthalmol. 1971 Aug; 86(2):189-93.
- The function of the corneal epithelium in health and disease. The Jonas S. Friedenwald Memorial Lecture. Invest Ophthalmol. 1971 Jun; 10(6):383-407.
- Corneal glucose concentration. Flux in the presence and absence of epithelium. Arch Ophthalmol. 1971 Apr; 85(4):467-72.
- The relation of the corneal surface to the permanence of glued-on contact lenses. Can J Ophthalmol. 1971 Apr; 6(2):98-103.
- Characterization of collagenolytic activity in the ulcerating cornea. Exp Eye Res. 1971 Mar; 11(2):255-7.
- In vivo determination of corneal swelling pressure. Exp Eye Res. 1971 Mar; 11(2):220-9.
- Mobile infusion pumps for continuous delivery of fluid and therapeutic agents to the eye. Ann Ophthalmol. 1971 Feb; 3(2):126-8.
- New concepts in ocular xerosis. Trans Ophthalmol Soc U K (1962). 1971; 91:105-18.
- The effect of intraocular surgery on clear corneal grafts. Am J Ophthalmol. 1970 Nov; 70(5):719-21.
- Collagenolytic activity in experimental herpes simplex keratitis. Arch Ophthalmol. 1970 Oct; 84(4):516-9.
- Effect of a corneal fluid barrier on the nutrition of the epithelium. Exp Eye Res. 1970 Apr; 9(2):254-9.
- Effect of cataract surgery on the cornea. Trans Am Acad Ophthalmol Otolaryngol. 1970 Mar-Apr; 74(2):369-74.
- Collagenase and the cornea. Surv Ophthalmol. 1970 Mar; 14(5):402-15.
- Dry eye syndromes. Int Ophthalmol Clin. 1970; 10(2):215-51.
- Physiological response of the cornea to an artificial epithelium. Exp Eye Res. 1970 Jan; 9(1):158-64.
- The precorneal tear film. I. Factors in spreading and maintaining a continuous tear film over the corneal surface. Arch Ophthalmol. 1970 Jan; 83(1):89-94.
- Further experience with glued-on contact lens (artificial epithelium). Arch Ophthalmol. 1970 Jan; 83(1):10-20.
- Evaporation rate of water from the precorneal tear film and cornea in the rabbit. Invest Ophthalmol. 1969 Dec; 8(6):613-9.
- [Intraocular pressure without the ciliary body]. Arch Ophtalmol Rev Gen Ophtalmol. 1969 Dec; 29(12):849-54.
- Swelling properties of dogfish cornea. Exp Eye Res. 1969 Oct; 8(4):429-37.
- The role of collagenase in the alkali-burned cornea. Am J Ophthalmol. 1969 Sep; 68(3):478-83.
- The tensile strength of adhesive joints between eye tissues and alloplastic materials. Am J Ophthalmol. 1969 Aug; 68(2):248-55.
- Peptidase in the cornea. Exp Eye Res. 1969 Jul; 8(3):364-8.
- Collagenase in the cornea. Exp Eye Res. 1969 Jul; 8(3):369-73.
- Coagenase in corneal ulcerations. Arch Ophthalmol. 1969 Jul; 82(1):108-11.
- Contact lens glued to Bowman's membrane: a review. Am J Optom Arch Am Acad Optom. 1969 Jun; 46(6):434-9.
- Clinical applications of adhesives in corneal surgery. Trans Am Acad Ophthalmol Otolaryngol. 1969 May-Jun; 73(3):499-505.
- Replacement of the corneal epithelium with a contact lens (artificial epithelium). Trans Am Acad Ophthalmol Otolaryngol. 1969 May-Jun; 73(3):482-93.
- [Prevention of ulcers of the corneal stroma with the use of calcium salt of EDTA]. Arch Ophtalmol Rev Gen Ophtalmol. 1969 May; 29(5):389-92.
- The basement membrane of the human cornea in recurrent epithelial erosion syndrome. Trans Am Acad Ophthalmol Otolaryngol. 1969 May-Jun; 73(3):471-81.
- [Double-plate corneal prostheses maintained with the aid of surgical adhesives]. Arch Ophtalmol Rev Gen Ophtalmol. 1969 Mar; 29(3):169-74.
- Changes in the biosynthesis of corneal glycosaminoglycans during wound healing. Exp Eye Res. 1969 Jan; 8(1):69-76.
- The use of adhesives in anterior segment surgery. Trans Pac Coast Otoophthalmol Soc Annu Meet. 1969; 50:121-35.
- [Nutrition of the cornea having a water impermeable membrane as artificial endothelium]. Ber Zusammenkunft Dtsch Ophthalmol Ges. 1969; 69:546-50.
- The use of adhesive for the closure of corneal perforations. Report of two cases. Arch Ophthalmol. 1968 Dec; 80(6):705-9.
- Evaluation of adhesives for corneal surgery. Arch Ophthalmol. 1968 Nov; 80(5):645-56.
- The effect of the absence of corneal epithelium or endothelium on the stromal keratocytes. Invest Ophthalmol. 1968 Oct; 7(5):520-34.
- Optical properties of buried corneal silicone prostheses. Am J Ophthalmol. 1968 Oct; 66(4):633-40.
- Structural alterations affecting transparency in swollen human corneas. Invest Ophthalmol. 1968 Oct; 7(5):501-19.
- Machining donor material for keratoplasty. Am J Ophthalmol. 1968 Aug; 66(2):341-3.
- The tensile strength of corneal wounds. Arch Ophthalmol. 1968 May; 79(5):595-602.
- Artificial corneal epithelium. Arch Ophthalmol. 1968 Mar; 79(3):360.
- The artificial corneal endothelium. Surgical techniques and management. Arch Ophthalmol. 1968 Feb; 79(2):150-8.
- Treatment of chronic corneal edema: summary. Int Ophthalmol Clin. 1968; 8(3):757-9.
- Alloplastic implants in corneal edema. Int Ophthalmol Clin. 1968; 8(3):729-56.
- Recent advances in the use of alloplastic materials in ocular surgery. Doc Ophthalmol. 1968; 25(1):1-20.
- Penetrating keratoplasty. Int Ophthalmol Clin. 1968; 8(3):655-95.
- Medical treatment of corneal edema. Int Ophthalmol Clin. 1968; 8(3):601-10.
- [Useof preserved non-viable cornea in penetrating keratoplasty with an artificial endothelium]. Arch Ophtalmol Rev Gen Ophtalmol. 1967 Dec; 27(8):747-54.
- Replacement of the endothelium with alloplastic material: a new technique in corneal surgery. Trans Am Acad Ophthalmol Otolaryngol. 1967 Sep-Oct; 71(5):851-64.
- Corneal autografts. Am J Ophthalmol. 1967 Jun; 63(6):1677-81.
- A technique for the repair of perforated corneal ulcers. Arch Ophthalmol. 1967 Apr; 77(4):519-25.
- The Riley-Day syndrome. Ocular manifestations in a 35-year-old patient. Am J Ophthalmol. 1967 Mar; 63(3):523-4.
- Synthetic polymers in corneal surgery. I. Glyceryl methacrylate. Arch Ophthalmol. 1967 Feb; 77(2):252-7.
- The recurrence of herpetic keratitis following idoxuridine therapy. Am J Ophthalmol. 1967 Jan; 63(1):103-7.
- [Artificial endothelium]. Bull Mem Soc Fr Ophtalmol. 1967; 80:56-62.
- [Corneal edema and its therapy]. Ganka. 1966 Nov; 8(11):919-23.
- Treatment of corneal edema with a buried implant. Trans Am Acad Ophthalmol Otolaryngol. 1966 Mar-Apr; 70(2):267-80.
- Corticosteroids in corneal surgery. Int Ophthalmol Clin. 1966; 6(4):845-68.
- Corneal edema and intraocular pressure. II. Clinical results. Arch Ophthalmol. 1965 Oct; 74(4):477-84.
- Incorporation of sulfate-35S, N-acetylglucosamine-1-14C, glucose-1-14C, and galactose-1-14C into calf and beef corneal glycosaminoglycans. Invest Ophthalmol. 1965 Oct; 4(5):867-71.
- CORNEAL EDEMA AND INTRAOCULAR PRESSURE. 1. ANIMAL EXPERIMENTS. Arch Ophthalmol. 1965 Sep; 74:375-81.
- LONG-TERM TREATMENT WITH IDOXURIDINE AND STEROIDS: A COMPLICATION IN HERPETIC KERATITIS. Arch Ophthalmol. 1965 Aug; 74:172-4.
- DISLOCATION OF DESCEMET'S MEMBRANE DURING KERATOPLASTY. Am J Ophthalmol. 1965 Jul; 60:43-5.
- A BURIED CORNEAL IMPLANT SERVING AS A BARRIER TO FLUID. Arch Ophthalmol. 1965 May; 73:635-9.
- CORNEAL EDEMA AFTER CATARACT SURGERY. Int Ophthalmol Clin. 1964 Dec; 4:979-98.
- CORTICOSTEROIDS IN CORNEAL WOUND HEALING. Am J Ophthalmol. 1964 Oct; 58:621-6.
- IDU IN CORNEAL WOUNDHEALING. Am J Ophthalmol. 1964 Jun; 57:999-1002.
- [EXPERIMENTAL TRANSPLANTATIONS OF CARTILAGINOUS TISSUE ON THE CORNEA]. Ann Ocul (Paris). 1964 Apr; 197:375-88.
- CORNEA AND SCLERA. Arch Ophthalmol. 1964 Feb; 71:249-63.
- CORNEA AND SCLERA. Arch Ophthalmol. 1964 Feb; 71:249-63.
- HERPES SIMPLEX TREATMENT WITH IDU AND CORTICOSTEROIDS. Trans Am Acad Ophthalmol Otolaryngol. 1963 Sep-Oct; 67:695-701.
- A new method for the determination of the swelling pressure of the corneal stroma in vitro. Exp Eye Res. 1963 Apr; 2:122-9.
- Herpes simplex treatment with IDU and corticosteroids. Arch Ophthalmol. 1963 Apr; 69:468-72.
- Cornea and sclera. Arch Ophthalmol. 1963 Feb; 69:257-78.
- Silicone oil in the anterior chamber of the eye. Effect on corneal hydration. Acta Ophthalmol (Copenh). 1963; 41:75-9.
- Use of 5-iodo-2'-deoxyuridine (IDU) in treatment of herpes simplex keratitis. Arch Ophthalmol. 1962 Aug; 68:235-9.
- The swelling pressure of the corneal stroma. Invest Ophthalmol. 1962 Apr; 1:158-62.
- Nonviable donor material for lamellar keratoplasty. Arch Ophthalmol. 1961 Sep; 66:343-6.
- [Problems and possibilities of keratoplasty]. Sven Lakartidn. 1960 Jun 10; 57:1785-94.
- Delayed clouding in corneal grafts. Acta Ophthalmol (Copenh). 1960; 38:242-6.
- Storage of corneas in the frozen state for keratoplasty; influence of glycerol pretreatment on the viability of stromal cells. Acta Ophthalmol (Copenh). 1959; 37(2):112-8.
- Metabolism and healing of the corneal graft. Acta Ophthalmol (Copenh). 1958; 36(3):405-6.
- [Essential conditions for corneal transplantation]. Sven Lakartidn. 1957 Oct 04; 54(40):2969-79.
- The swelling pressure of the ox corneal stroma. Acta Ophthalmol (Copenh). 1957; 35(2):73-84.
- Influence of the intraocular pressure on hydration of the corneal stroma. Acta Ophthalmol (Copenh). 1957; 35(2):85-90.
- Incorporation of radioactive sulfate into the rabbit eye. Acta Ophthalmol (Copenh). 1957; 35(2):115-30.
- On the metabolism of the corneal graft. Acta Ophthalmol (Copenh). 1957; 35(4):303-10.
- Carbohydrate-containing protein fractions in the corneal stroma. Acta Ophthalmol (Copenh). 1957; 35(5):454-60.
- On the fate of the corneal graft. Acta Ophthalmol (Copenh). 1957; 35(4):286-302.
- The fate of the sulfate group of chondroitin sulfate after administration to rats. Acta Physiol Scand. 1956 Sep 26; 37(2-3):220-34.
- The viability of the stored cornea. Acta Ophthalmol (Copenh). 1956; 34(4):281-92.
- Pitfalls in histochemistry: an unsuccessful attempt to demonstrate mucoid sulfatase activity in mammalian tissue. J Histochem Cytochem. 1955 Nov; 3(6):492-4.
- Chemical studies on Descemet's membrane of the bovine cornea. Arch Biochem Biophys. 1955 Aug; 57(2):445-57.
- Uptake of sulfate by mucopolysaccharides in the rat cornea and sclera. Acta Ophthalmol (Copenh). 1955; 33(4):455-61.
- Mitotic and wound healing activities in the rat corneal epithelium; influence of various hormones and endocrine glands. AMA Arch Ophthalmol. 1954 Nov; 52(5):751-7.
- The Dorn-Sugarman test. Acta Obstet Gynecol Scand Suppl. 1950; 30(Suppl. 7):422-7.
- The effect on acid-base balance of anesthesia combined with renal insufficiency. Acta Pharmacol Toxicol (Copenh). 1949 Aug 15; 5(2):164-72.
- The reaction of Dorn and Sugarman. Gynecol Obstet (Paris). 1949; 48(5):474-9.
Show More
Show Less
